DexCom (DXCM) Competitors

DexCom (NASDAQ:DXCM) and Medtronic (NYSE:MDT) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, media sentiment, risk, earnings, institutional ownership, analyst recommendations, valuation and profitability.

Is DXCM or MDT more profitable?

Medtronic has a net margin of 13.90% compared to DexCom's net margin of 12.90%. DexCom's return on equity of 30.05% beat Medtronic's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DexCom	12.90%	30.05%	10.00%
Medtronic	13.90%	14.54%	7.83%

Do analysts prefer DXCM or MDT?

DexCom presently has a consensus price target of $98.50, suggesting a potential upside of 12.84%. Medtronic has a consensus price target of $97.87, suggesting a potential upside of 12.17%. Given DexCom's stronger consensus rating and higher probable upside, analysts clearly believe DexCom is more favorable than Medtronic.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DexCom	0 Sell rating(s)	4 Hold rating(s)	15 Buy rating(s)	3 Strong Buy rating(s)	2.95
Medtronic	0 Sell rating(s)	9 Hold rating(s)	8 Buy rating(s)	2 Strong Buy rating(s)	2.63

Does the media prefer DXCM or MDT?

In the previous week, Medtronic had 25 more articles in the media than DexCom. MarketBeat recorded 57 mentions for Medtronic and 32 mentions for DexCom. Medtronic's average media sentiment score of 1.29 beat DexCom's score of 1.05 indicating that Medtronic is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DexCom	19 Very Positive mention(s)	2 Positive mention(s)	7 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
Medtronic	44 Very Positive mention(s)	3 Positive mention(s)	8 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more risk and volatility, DXCM or MDT?

DexCom has a beta of 1.46, suggesting that its share price is 46% more volatile than the S&P 500. Comparatively, Medtronic has a beta of 0.79, suggesting that its share price is 21% less volatile than the S&P 500.

Do insiders and institutionals hold more shares of DXCM or MDT?

97.8% of DexCom shares are held by institutional investors. Comparatively, 82.1% of Medtronic shares are held by institutional investors. 0.3% of DexCom shares are held by insiders. Comparatively, 0.2% of Medtronic shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Which has better earnings and valuation, DXCM or MDT?

Medtronic has higher revenue and earnings than DexCom. Medtronic is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DexCom	$4.03B	8.49	$576.20M	$1.34	65.14
Medtronic	$33.54B	3.34	$4.66B	$3.62	24.10

Summary

DexCom beats Medtronic on 11 of the 17 factors compared between the two stocks.